ACCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines: A Focused Update of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use
ACCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines: A Focused Update of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use
复制标题
DOI：
10.1038/ajg.2010.445
复制
发表时间：
2010-12-01
影响因子：
9.8
通讯作者：
Tomaselli, Gordon F.
中科院分区：
文献类型：
--
作者：
Abraham, Neena S.;Hlatky, Mark A.;Tomaselli, Gordon F.
这份专家共识文件是由美国心脏病学会基金会（ACCF）、美国胃肠病学学会（ACG）和美国心脏协会（AHA）共同制定的。专家共识文件将ACCF和文件共同发起人关于临床实践或医疗技术发展领域的意见告知从业人员、支付方和其他利益相关方。专家共识文件涵盖了证据基础、技术经验或临床实践被认为不够完善，无法通过正式的ACCF/AHA实践指南过程进行评估的主题。通常情况下，这个话题是正在进行的大量调查的主题。因此，读者应该将专家共识文件视为ACCF和文件共同发起人在尚未获得严格证据的领域告知临床实践的最佳尝试。为避免由于撰写委员会之间的行业关系或个人利益而可能产生的实际、潜在或感知的利益冲突，要求撰写委员会的所有成员以及文件的同行审稿人在撰写工作开始前12个月披露所有当前的卫生保健相关关系和现有的关系。ACCF临床专家共识文件工作组（CECD）审查这些披露，以确定哪些公司生产的产品（已上市或正在开发）与正在开发的文件相关。根据这些信息，成立了一个写作委员会，其中包括大多数与行业没有相关关系的成员（RWI），由一个没有相关RWI的主席领导。具有相关RWI的作者不允许起草或投票与其RWI相关的文本或建议。在所有电话会议上审查RWI，并在发生变化时进行更新。与本文档相关的作者和同行审稿人RWI分别在附录1和附录2中披露。此外，为了确保完全透明，作者的全面披露信息（包括与本文档无关的RWI）可在网上获得。ACCF特别工作小组的公开资料也可在网上（www.cardiosource.org/ACC/About-ACC/Leadership/Guidelines-and-Documents-Task-Forces.aspx）查阅，ACCF文件开发的公开政策也可在网上（www.cardiosource.org/Science-And-Quality/Practice-Guidelines-and-Quality-Standards/Relationships-With-Industry-Policy.aspx.The）查阅。撰写委员会的工作完全由ACCF支持，没有任何商业支持。写作委员会成员自愿为这项工作贡献时间。写作委员会的电话会议是保密的，只有委员会成员参加。
This expert consensus document was developed by the American College of Cardiology Foundation (ACCF), the American College of Gastroenterology (ACG), and the American Heart Association (AHA). Expert consensus documents inform practitioners, payers, and other interested parties of the opinion of ACCF and document cosponsors concerning evolving areas of clinical practice or medical technologies. Expert consensus documents cover topics for which the evidence base, experience with technology, or clinical practice is not considered sufficiently well developed to be evaluated by the formal ACCF/AHA Practice Guidelines process. Often, the topic is the subject of considerable ongoing investigation. Thus, the reader should view the expert consensus document as the best attempt of the ACCF and document cosponsors to inform clinical practice in areas where rigorous evidence may not yet be available.To avoid actual, potential, or perceived conflicts of interest that may arise as a result of industry relationships or personal interests among the writing committee, all members of the writing committee, as well as peer reviewers of the document, are asked to disclose all current health care-related relationships and those existing 12 months before initiation of the writing effort. The ACCF Task Force on Clinical Expert Consensus Documents (CECD) reviews these disclosures to determine which companies make products (on market or in development) that pertain to the document under development. Based on this information, a writing committee is formed to include a majority of members with no relevant relationships with industry (RWI), led by a chair with no relevant RWI. Authors with relevant RWI are not permitted to draft or vote on text or recommendations pertaining to their RWI. RWI are reviewed on all conference calls and updated as changes occur. Author and peer reviewer RWI pertinent to this document are disclosed in Appendixes 1 and 2, respectively. Additionally, to ensure complete transparency, authors' comprehensive disclosure information-including RWI not pertinent to this document-is available online. Disclosure information for the ACCF Task Force on CECD is also available online at www.cardiosource.org/ACC/About-ACC/Leadership/Guidelines-and-Documents-Task-Forces.aspx, as well as the ACCF disclosure policy for document development at www.cardiosource.org/Science-And-Quality/Practice-Guidelines-and-Quality-Standards/Relationships-With-Industry-Policy.aspx.The work of the writing committee was supported exclusively by the ACCF without commercial support. Writing committee members volunteered their time to this effort. Conference calls of the writing committee were confidential and attended only by committee members.